|Bid||281.50 x 1000|
|Ask||283.93 x 100|
|Day's Range||280.24 - 291.91|
|52 Week Range||244.28 - 333.65|
|PE Ratio (TTM)||17.72|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Biogen Inc. said its interactions with health-care providers in Italy are under investigation by a prosecutor in Milan.
Biogen popped early Tuesday after its spinal drug nearly tripled expectations in the second quarter, leading to a 4% guidance boost.
On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of $4.07. Earnings, adjusted for one-time gains and costs, came to $5.04 per share. The results surpassed Wall Street ...